ArticleThe Journal of clinical psychiatry2025

Aripiprazole or Bupropion Augmentation Versus Switching to Bupropion in Treatment-Resistant Depression: A Risk-Benefit Analysis.

William U Meyerson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.